Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,071 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
Pichon S, Moureau A, Petit C, Kirstein JL, Sheldon E, Guinet-Morlot F, Minutello AM. Pichon S, et al. Among authors: petit c. Vaccine. 2024 Apr 11;42(10):2553-2559. doi: 10.1016/j.vaccine.2023.11.052. Epub 2023 Dec 16. Vaccine. 2024. PMID: 38105138 Free article.
Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
Quiambao BP, Ambas C, Diego S, Bosch Castells V, Korejwo J, Petit C, Houillon G. Quiambao BP, et al. Among authors: petit c. Vaccine. 2019 Apr 10;37(16):2268-2277. doi: 10.1016/j.vaccine.2019.02.083. Epub 2019 Mar 16. Vaccine. 2019. PMID: 30890382 Free article. Clinical Trial.
Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines.
Quiambao BP, Ambas C, Diego S, Bosch Castells V, Korejwo J, Petit C, Rasuli A, Houillon G. Quiambao BP, et al. Among authors: petit c. Vaccine. 2020 May 6;38(21):3740-3746. doi: 10.1016/j.vaccine.2020.03.043. Epub 2020 Apr 9. Vaccine. 2020. PMID: 32280042 Free article. Clinical Trial.
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.
Quiambao BP, Lim JG, Bosch Castells V, Augard C, Petit C, Bravo C, Delore V, Houillon G. Quiambao BP, et al. Among authors: petit c. Vaccine. 2022 Aug 26;40(36):5347-5355. doi: 10.1016/j.vaccine.2022.07.037. Epub 2022 Aug 3. Vaccine. 2022. PMID: 35933278 Free article. Clinical Trial.
Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults.
Pichon S, Guinet-Morlot F, Saleh J, Essink B, Pineda-Peña AC, Moureau A, Petit C, Minutello AM. Pichon S, et al. Among authors: petit c. Hum Vaccin Immunother. 2023 Dec 15;19(3):2275453. doi: 10.1080/21645515.2023.2275453. Epub 2023 Nov 3. Hum Vaccin Immunother. 2023. PMID: 37921410 Free PMC article. Clinical Trial.
Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
Pineda-Peña AC, Jiang Q, Petit C, Korejwo-Peyramond J, Donazzolo Y, Latreille M, Homery MC, Babin V, Benamor S, Pichon S, Guinet-Morlot F, Minutello AM. Pineda-Peña AC, et al. Among authors: petit c. Clin Infect Dis. 2024 Jun 14;78(6):1748-1756. doi: 10.1093/cid/ciae137. Clin Infect Dis. 2024. PMID: 38478634 Free PMC article. Clinical Trial.
Randomized Controlled Trial of the Immunogenicity and Safety of a Serum-Free Purified Vero Rabies Vaccine (PVRV-NG2) Using a Simulated Postexposure Zagreb Regimen With Human Rabies Immunoglobulin in Adults in Thailand.
Chansinghakul D, Tantawichien T, Limkittikul K, Ratanasuwan W, Wang Y, Petit C, Guinet-Morlot F, Frago C, Pineda-Peña AC. Chansinghakul D, et al. Among authors: petit c. Open Forum Infect Dis. 2024 Oct 25;11(11):ofae633. doi: 10.1093/ofid/ofae633. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39544495 Free PMC article.
Non-inferiority study of purified Vero rabies vaccine - serum free in three-dose and two-dose pre-exposure prophylaxis regimens in comparison with licensed rabies vaccines.
Chokephaibulkit K, Huoi C, Tantawichien T, Mootsikapun P, Kosalaraksa P, Kiertiburanakul S, Ratanasuwan W, Vangelisti M, Laot T, Huang Y, Petit C, Pineda-Peña AC, Frago C. Chokephaibulkit K, et al. Among authors: petit c. Clin Infect Dis. 2024 Nov 26:ciae581. doi: 10.1093/cid/ciae581. Online ahead of print. Clin Infect Dis. 2024. PMID: 39587931
1,071 results